DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Simon TG, Bonilla H, Yan P. et al.
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.

Hepatology 2016;
64: 47-57

Download Bibliographical Data

Search in:
Access: